Phase 1/1B trial of the heat shock protein 90 inhibitor NVP-AUY922 as monotherapy or in combination with bortezomib in patients with relapsed or refractory multiple myeloma

Citation metadata

Authors: Ruth Seggewiss-Bernhardt, Ralf C. Bargou, Yeow Tee Goh, A. Keith Stewart, Andrew Spencer and Adrian Alegre
Date: July 1, 2015
From: Cancer(Vol. 121, Issue 13)
Publisher: J.B. Lippincott Company
Document Type: Report

Document controls

Format Options:
Translate Article
Set Interface Language
Colors:
Font:
Open SansEB GaramondOpen DyslexicNoto Sans
DefaultMoreMost
Line Spacing
Letter Spacing
Word Spacing

Main content

Source Citation

Source Citation   

Gale Document Number: GALE|A421203205